Matheus H. Dias
Sao Paulo, SP 05508000, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
A combination of protein phosphatase 2A inhibition and checkpoint immunotherapy: a perfect storm.
Journal: Molecular oncology
Published: April 15, 2024
Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in KRAS-mutant cancers.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 20, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy.
Journal: Cancer discovery
Published: February 21, 2023
Correction: Autophagy buffers Ras-induced genotoxic stress enabling malignant transformation in keratinocytes primed by human papillomavirus.
Journal: Cell death & disease
Published: March 18, 2021
Playing cancer at its own game: activating mitogenic signaling as a paradoxical intervention.
Journal: Molecular oncology
Published: February 15, 2021
Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells.
Journal: Cancers
Published: January 27, 2021
Autophagy buffers Ras-induced genotoxic stress enabling malignant transformation in keratinocytes primed by human papillomavirus.
Journal: Cell death & disease
Published: October 14, 2020
EGFR activation limits the response of liver cancer to lenvatinib.
Journal: Nature
Published: May 08, 2020
Human B cells infected by Trypanosoma cruzi undergo F-actin disruption and cell death via caspase-7 activation and cleavage of phospholipase Cγ1.
Journal: Immunobiology
Published: September 20, 2019
Last Updated: 09/26/2026